NVO

Novo Nordisk A/S

$46.61

0.33 (0.71%) Today

0.09 (0.19%) After-hours

— up— down

Compare NVO

Market Cap

$1.33T-8.2%

Revenue (TTM)

$251.77B+5.6%

Net Income (TTM)

$88.76B+4.9%

EPS (TTM)

26.18+4.9%

Shares Out

3.39B

P/E Ratio

11.40

Forward P/E

14.36

Dividend

$11.66 (3.91%)

Ex-Dividend Date

Mar 30, 2026

Open

$45.96

Previous Close

$46.39

Day Range

$45.73 – $46.79

52-Week Range

$35.12 – $64.16

Beta

1.92

Volume

9.68M

Avg Volume

5.22M

Analyst Rating

Hold

Exchange

OMX NORDIC EXCHANGE COPENHAGEN A/S

About NVO

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority (77.1%) of its voting shares.